Table 1.
Clinical and biological characteristics of DLBCL patients (N = 102).
| DLBCL (N = 102) | Low JAM-A | High JAM-A | P-Value |
|---|---|---|---|
| Age | |||
| >60 years | 23 | 23 | 0.8424 |
| ≤60 years | 26 | 30 | |
| Sex | |||
| Female | 20 | 24 | 0.6924 |
| Male | 29 | 29 | |
| Extranodal involvement | |||
| >1 | 8 | 19 | 0.0421 |
| ≤1 | 41 | 34 | |
| Ann Arbor Stage | |||
| I to II | 20 | 22 | 1.0000 |
| III to IV | 29 | 31 | |
| IPI Score | |||
| Low to intermediate low risk (0–2) | 25 | 29 | 0.8428 |
| Intermediate high to high risk (3–5) | 24 | 24 | |
| Cell of origin | |||
| Germinal center B-cell | 18 | 20 | 1.000 |
| Non-germinal center B-cell | 30 | 33 | |
| Treatment response | |||
| CR | 42 | 33 | 0.0126 |
| Non-CR | 7 | 20 | |
| DLBCL with extranodal lesions (N = 75) | Low JAM-A | High JAM-A | P-Value |
| Extranodal involvement | |||
| >1 | 8 | 19 | 0.0294 |
| =1 | 28 | 20 | |